121 related articles for article (PubMed ID: 32427381)
21. Exercise training decreases NADPH oxidase activity and restores skeletal muscle mass in heart failure rats.
Cunha TF; Bechara LR; Bacurau AV; Jannig PR; Voltarelli VA; Dourado PM; Vasconcelos AR; Scavone C; Ferreira JC; Brum PC
J Appl Physiol (1985); 2017 Apr; 122(4):817-827. PubMed ID: 28104751
[TBL] [Abstract][Full Text] [Related]
22. Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses.
Nissinen TA; Hentilä J; Penna F; Lampinen A; Lautaoja JH; Fachada V; Holopainen T; Ritvos O; Kivelä R; Hulmi JJ
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):514-529. PubMed ID: 29722201
[TBL] [Abstract][Full Text] [Related]
23. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.
Zhou X; Wang JL; Lu J; Song Y; Kwak KS; Jiao Q; Rosenfeld R; Chen Q; Boone T; Simonet WS; Lacey DL; Goldberg AL; Han HQ
Cell; 2010 Aug; 142(4):531-43. PubMed ID: 20723755
[TBL] [Abstract][Full Text] [Related]
24. Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress.
Veeraveedu PT; Sanada S; Okuda K; Fu HY; Matsuzaki T; Araki R; Yamato M; Yasuda K; Sakata Y; Yoshimoto T; Minamino T
Biochem Pharmacol; 2017 Aug; 138():73-80. PubMed ID: 28450225
[TBL] [Abstract][Full Text] [Related]
25. Leukocyte iNOS is required for inflammation and pathological remodeling in ischemic heart failure.
Kingery JR; Hamid T; Lewis RK; Ismahil MA; Bansal SS; Rokosh G; Townes TM; Ildstad ST; Jones SP; Prabhu SD
Basic Res Cardiol; 2017 Mar; 112(2):19. PubMed ID: 28238121
[TBL] [Abstract][Full Text] [Related]
26. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.
van Rooij E; Doevendans PA; Crijns HJ; Heeneman S; Lips DJ; van Bilsen M; Williams RS; Olson EN; Bassel-Duby R; Rothermel BA; De Windt LJ
Circ Res; 2004 Feb; 94(3):e18-26. PubMed ID: 14739160
[TBL] [Abstract][Full Text] [Related]
27. Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes.
Nissinen TA; Degerman J; Räsänen M; Poikonen AR; Koskinen S; Mervaala E; Pasternack A; Ritvos O; Kivelä R; Hulmi JJ
Sci Rep; 2016 Sep; 6():32695. PubMed ID: 27666826
[TBL] [Abstract][Full Text] [Related]
28. The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy.
Samant SA; Kanwal A; Pillai VB; Bao R; Gupta MP
Sci Rep; 2017 Sep; 7(1):11877. PubMed ID: 28928419
[TBL] [Abstract][Full Text] [Related]
29. Murine FSH Production Depends on the Activin Type II Receptors ACVR2A and ACVR2B.
Schang G; Ongaro L; Schultz H; Wang Y; Zhou X; Brûlé E; Boehm U; Lee SJ; Bernard DJ
Endocrinology; 2020 Jul; 161(7):. PubMed ID: 32270195
[TBL] [Abstract][Full Text] [Related]
30. The effects of parathyroid hormone-related peptide on cardiac angiogenesis, apoptosis, and function in mice with myocardial infarction.
Zhang H; Gao Y; Wang Y; Yan Y; Yang Z; Miao D; Zhang D
J Cell Biochem; 2019 Sep; 120(9):14745-14755. PubMed ID: 30994964
[TBL] [Abstract][Full Text] [Related]
31. Akt/mTOR pathway contributes to skeletal muscle anti-atrophic effect of aerobic exercise training in heart failure mice.
Bacurau AV; Jannig PR; de Moraes WM; Cunha TF; Medeiros A; Barberi L; Coelho MA; Bacurau RF; Ugrinowitsch C; Musarò A; Brum PC
Int J Cardiol; 2016 Jul; 214():137-47. PubMed ID: 27060274
[TBL] [Abstract][Full Text] [Related]
32. Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction.
Matsumoto K; Obana M; Kobayashi A; Kihara M; Shioi G; Miyagawa S; Maeda M; Sakata Y; Nakayama H; Sawa Y; Fujio Y
Cardiovasc Res; 2019 Mar; 115(4):765-775. PubMed ID: 30307485
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
Travers JG; Kamal FA; Valiente-Alandi I; Nieman ML; Sargent MA; Lorenz JN; Molkentin JD; Blaxall BC
J Am Coll Cardiol; 2017 Aug; 70(8):958-971. PubMed ID: 28818206
[TBL] [Abstract][Full Text] [Related]
34. Load-Dependent Changes in Left Ventricular Structure and Function in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure.
Weinheimer CJ; Kovacs A; Evans S; Matkovich SJ; Barger PM; Mann DL
Circ Heart Fail; 2018 May; 11(5):e004351. PubMed ID: 29716898
[TBL] [Abstract][Full Text] [Related]
35. Skeletal muscle derived Musclin protects the heart during pathological overload.
Szaroszyk M; Kattih B; Martin-Garrido A; Trogisch FA; Dittrich GM; Grund A; Abouissa A; Derlin K; Meier M; Holler T; Korf-Klingebiel M; Völker K; Garfias Macedo T; Pablo Tortola C; Boschmann M; Huang N; Froese N; Zwadlo C; Malek Mohammadi M; Luo X; Wagner M; Cordero J; Geffers R; Batkai S; Thum T; Bork N; Nikolaev VO; Müller OJ; Katus HA; El-Armouche A; Kraft T; Springer J; Dobreva G; Wollert KC; Fielitz J; von Haehling S; Kuhn M; Bauersachs J; Heineke J
Nat Commun; 2022 Jan; 13(1):149. PubMed ID: 35013221
[TBL] [Abstract][Full Text] [Related]
36. Activin Receptor Ligand Blocking and Cancer Have Distinct Effects on Protein and Redox Homeostasis in Skeletal Muscle and Liver.
Hentilä J; Nissinen TA; Korkmaz A; Lensu S; Silvennoinen M; Pasternack A; Ritvos O; Atalay M; Hulmi JJ
Front Physiol; 2018; 9():1917. PubMed ID: 30713500
[TBL] [Abstract][Full Text] [Related]
37. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Shiomi T; Tsutsui H; Hayashidani S; Suematsu N; Ikeuchi M; Wen J; Ishibashi M; Kubota T; Egashira K; Takeshita A
Circulation; 2002 Dec; 106(24):3126-32. PubMed ID: 12473562
[TBL] [Abstract][Full Text] [Related]
38. Regulation of muscle growth by multiple ligands signaling through activin type II receptors.
Lee SJ; Reed LA; Davies MV; Girgenrath S; Goad ME; Tomkinson KN; Wright JF; Barker C; Ehrmantraut G; Holmstrom J; Trowell B; Gertz B; Jiang MS; Sebald SM; Matzuk M; Li E; Liang LF; Quattlebaum E; Stotish RL; Wolfman NM
Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18117-22. PubMed ID: 16330774
[TBL] [Abstract][Full Text] [Related]
39. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
[TBL] [Abstract][Full Text] [Related]
40. Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy.
Castillero E; Akashi H; Wang C; Najjar M; Ji R; Kennel PJ; Sweeney HL; Schulze PC; George I
Biochem Biophys Res Commun; 2015 Jan; 457(1):106-11. PubMed ID: 25528587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
